# Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

> **NCT00014638** · PHASE4 · COMPLETED · sponsor: **Novartis**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** letrozole

## Key facts

- **NCT ID:** NCT00014638
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2002-03
- **Final completion:** 2002-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014638, "Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00014638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*